Christine Greco
Physician Assistant · Smithtown, NYNPI 1750610978
Payments from drug & device makers
Across 192 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$677
- AbbVie$597
- Novo Nordisk$547
- Lilly USA, LLC$399
- Idorsia Pharmaceuticals US Inc$233
- AstraZeneca$205
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,92599%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 12 | $677 |
| AbbVie(2 entities) | 37 | $597 |
| Novo Nordisk | 39 | $547 |
| Lilly USA, LLC | 21 | $399 |
| Idorsia Pharmaceuticals US Inc | 13 | $233 |
| AstraZeneca | 9 | $205 |
| Merz North America, Inc. | 2 | $156 |
| Amgen(2 entities) | 6 | $138 |
| Currax Pharmaceuticals LLC | 8 | $133 |
| GSK | 7 | $132 |
| Bausch Health US, LLC | 4 | $78 |
| Johnson & Johnson | 4 | $75 |
| Daiichi Sankyo Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Biohaven Pharmaceuticals, Inc. | 2 | $49 |
| Boehringer Ingelheim | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Novartis | 2 | $38 |
| Neurelis, Inc. | 2 | $36 |
| Boston Scientific | 1 | $35 |
| Merck | 2 | $25 |
| Lundbeck LLC | 1 | $22 |
| Biogen | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Intra-sana Laboratories | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,961 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $16,669 |
| MounjaroTirzepatide | 12 | $12,343 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $547 | $16,66912 claims |
| Lilly USA, LLCMounjaro | $399 | $12,34312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Smithtown
- Collin DuffySmithtown$40K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.